double blind trial prolactin inhibitor bromocriptine painful benign breast disease pubmed ncbi abstract double blind crossover trial prolactin inhibitor bromocriptine painful benign breast disease reported twenty-nine women cyclical mastalgia num non-cyclical pain treated bromocriptine num mg daily placebo menstrual cycels assessment response treatment made linear analogue system clinical examination plasma prolactin estimations bromocriptine produced significant improvement breast symptoms significant fall prolactin levels cyclical pain group effect non-cyclical group results suggest bromocriptine offers effective approach management cyclical breast pain 
